We are testing CNTY-101, a new cell therapy, for people with hard-to-treat B cell autoimmune diseases. The goal is to see if it can improve their condition compared to standard treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect various parts of the body, including the skin, joints, and organs. It can lead to conditions like lupus nephritis, which affects the kidneys, and idiopathic inflammatory myopathy, which causes muscle weakness. Diffuse cutaneous systemic sclerosis is another related condition that leads to skin thickening and can affect internal organs.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
